Zhejiang Wecome Pharmaceutical Company Limited’s Net Profit Dropped 53.3% in 2022

Zhejiang Wecome Pharmaceutical Company Limited (浙江维康药业股份有限公司) (300878.SZ) reported a net profit of 45.1 million yuan in 2022, down 53.3% year-on-year.

Meanwhile, the company posted 531.3 million yuan in revenue, down 16.1% year-on-year.

At the end of the reporting period, it had 1.9 billion yuan in total assets and 502.3 million yuan in total liabilities, with a liability-to-asset ratio of 26.2%.